1. Home
  2. TIVC vs VRAX Comparison

TIVC vs VRAX Comparison

Compare TIVC & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • VRAX
  • Stock Information
  • Founded
  • TIVC 2016
  • VRAX 2013
  • Country
  • TIVC United States
  • VRAX United Kingdom
  • Employees
  • TIVC N/A
  • VRAX N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • TIVC Health Care
  • VRAX Health Care
  • Exchange
  • TIVC Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • TIVC 4.9M
  • VRAX 4.4M
  • IPO Year
  • TIVC 2021
  • VRAX 2022
  • Fundamental
  • Price
  • TIVC $3.13
  • VRAX $0.64
  • Analyst Decision
  • TIVC
  • VRAX Strong Buy
  • Analyst Count
  • TIVC 0
  • VRAX 1
  • Target Price
  • TIVC N/A
  • VRAX $3.00
  • AVG Volume (30 Days)
  • TIVC 803.0K
  • VRAX 1.6M
  • Earning Date
  • TIVC 11-13-2025
  • VRAX 01-01-0001
  • Dividend Yield
  • TIVC N/A
  • VRAX N/A
  • EPS Growth
  • TIVC N/A
  • VRAX N/A
  • EPS
  • TIVC N/A
  • VRAX N/A
  • Revenue
  • TIVC $462,000.00
  • VRAX $6,331.00
  • Revenue This Year
  • TIVC N/A
  • VRAX $217,274.83
  • Revenue Next Year
  • TIVC N/A
  • VRAX N/A
  • P/E Ratio
  • TIVC N/A
  • VRAX N/A
  • Revenue Growth
  • TIVC N/A
  • VRAX N/A
  • 52 Week Low
  • TIVC $2.43
  • VRAX $0.52
  • 52 Week High
  • TIVC $15.64
  • VRAX $3.62
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 47.44
  • VRAX 46.78
  • Support Level
  • TIVC $2.98
  • VRAX $0.59
  • Resistance Level
  • TIVC $3.19
  • VRAX $0.70
  • Average True Range (ATR)
  • TIVC 0.13
  • VRAX 0.05
  • MACD
  • TIVC 0.04
  • VRAX 0.01
  • Stochastic Oscillator
  • TIVC 79.21
  • VRAX 69.66

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: